VTVT
vTv Therapeutics Inc
30.60$
-4.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -21.1% | -56.7% | +15.4% | +1,453.3% | +785.8% | +19.8% | +36.5% | +34.0% | -79.6% | +98.5% | -99.6% | -12.5% | +14.3% | -100.0% | – | +91,314.3% | -84.6% | -99.1% | +33,233.3% | -99.7% | +22,122.2% | -99.6% | -100.0% | – | -100.0% | – | -100.0% | – | – | -100.0% | – | – | -100.0% | – | – | – | – | -100.0% | – | |
| – | -0.6% | -1.3% | -12.2% | -6.6% | +12.0% | -11.2% | -3.9% | -68.6% | +3.8% | +0.8% | +49.8% | -13.4% | +20.3% | -4.6% | +59.7% | -73.7% | +43.3% | +22.5% | -21.5% | -2.3% | +97.4% | -33.4% | -29.6% | -98.9% | -4.2% | -4.3% | +4.5% | -4.3% | +4.5% | -4.3% | +4.5% | -4.3% | +0.0% | -59.1% | -66.7% | – | – | -50.0% | – | – | |
| – | – | – | – | – | – | – | – | – | +154.4% | -210.4% | – | – | – | – | -84,012.5% | – | – | -154.7% | – | – | -859.4% | – | – | – | – | -344.4% | – | – | – | – | -102.3% | – | – | – | – | – | – | – | – | – | |
| – | -0.6% | -1.3% | -12.2% | -6.6% | +12.0% | -11.2% | -3.9% | -68.6% | +3.8% | +0.8% | +49.8% | -13.4% | +20.3% | -4.6% | -40.3% | -29.5% | +43.3% | +22.5% | -21.5% | -2.3% | +126.8% | -42.0% | -29.6% | +38.5% | +29.8% | -0.6% | +19.0% | -39.8% | -24.3% | +23.9% | +29.8% | -6.3% | -30.7% | +26.7% | +45.0% | +71.1% | -44.3% | +129.7% | -2.3% | – | |
| – | -6.2% | +25.4% | +6.4% | -14.6% | +14.4% | -23.2% | +21.4% | -21.2% | -3.9% | +15.1% | +0.3% | -26.0% | +12.4% | +23.2% | -30.8% | -36.8% | +90.0% | +6.3% | +3.6% | -0.9% | +116.8% | +11.0% | -65.8% | +43.9% | -9.3% | +45.9% | -5.1% | -23.1% | +1.0% | +54.8% | -6.6% | -11.7% | -18.5% | +37.3% | -1.5% | +1.7% | +8.1% | +15.6% | +12.2% | – | |
| – | -1.6% | +3.2% | -8.4% | -8.5% | +12.5% | -13.9% | +1.2% | -57.1% | +0.4% | +6.9% | +27.1% | -17.9% | +17.7% | +4.1% | -137.7% | – | +90.0% | +6.3% | +3.6% | -0.9% | +188.9% | -16.6% | -65.8% | +210.7% | +11.7% | +16.9% | +7.7% | -32.9% | -12.3% | +40.8% | +8.0% | -9.1% | -24.9% | +33.1% | +18.7% | +38.6% | -26.3% | +72.2% | +2.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -333.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -159.9% | – | |
| – | +1,776.2% | +41.9% | +48.8% | +2.0% | +0.4% | +0.4% | +1.8% | -5.5% | -9.6% | -15.7% | -17.9% | -21.4% | -30.0% | -40.6% | +32.1% | +5.9% | -71.5% | -98.5% | -100.0% | – | +0.0% | -83.3% | +6,300.0% | -87.5% | -25.0% | +27,450.0% | -99.9% | +100.0% | +75.0% | – | – | – | – | – | – | – | -80.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -468.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -154.1% | – | |
| – | – | – | – | – | – | -867.8% | – | -107.0% | – | – | – | -2,202.0% | – | – | – | – | +12.5% | -95.9% | -1,653.3% | – | -214.9% | – | -570.0% | – | – | – | – | – | – | – | -1,329.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -476.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -154.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -329.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -154.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.